Latest Pharmacy Daily headlines

Fri 19 Jan 18

S3 advertising permitted

Pharmacy Daily

THE Therapeutic Goods Administration has confirmed that the advertising of Schedule 3 (Pharmacist Only) medicines is to be allowed, along with the implementation of a more timely "switch" process facilitating rescheduling of Schedule 4 medicines to S3 and/or S2.

Fri 19 Jan 18

Codeine story ‘misleading’

WHILE the rescheduling of products containing codeine has been based mainly on the fact that codeine can cause dependence, and its misuse has led to addiction and even death, it is "misleading" to argue that withdrawing the products from OTC sale will reduce codeine use, according to University of Sydney Honorary Professor of Pharmacology Peter Carroll (pictured).

Thu 18 Jan 18

SHPA affirms codeine move

THE Society of Hospital Pharmacists of Australia has recommitted its support for the rescheduling of OTC codeine products, which will become prescription only from 01 Feb 2018.

Wed 17 Jan 18

PSA seals diabetes deal

THE Pharmaceutical Society of Australia (PSA) has signed a new Memorandum of Understanding with the Australian Diabetes Educators Association (ADEA).

Tue 16 Jan 18

E-cigarette research boost

IN WHAT could prove to be a game-changer for the marketing of e-cigarettes, or vaping devices, various experts from the EU and UK have argued that a switch policy to move tobacco smokers across to e-cigarettes would be pro-health.

Tue 16 Jan 18

Fred IT links with AMH

FRED IT Group and the Australian Medicines Handbook have announced a partnership which will provide users of the cloud-based solution Fred NXT system with direct access to the Australian Medicines Handbook (AMH) medicines information.

View All news articles Subscribe to the Newsletter